U.S. flag

An official website of the United States government

NM_000251.3(MSH2):c.2516A>G (p.His839Arg) AND Malignant tumor of breast

Germline classification:
Uncertain significance (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001354097.3

Allele description [Variation Report for NM_000251.3(MSH2):c.2516A>G (p.His839Arg)]

NM_000251.3(MSH2):c.2516A>G (p.His839Arg)

Gene:
MSH2:mutS homolog 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p21
Genomic location:
Preferred name:
NM_000251.3(MSH2):c.2516A>G (p.His839Arg)
HGVS:
  • NC_000002.12:g.47480753A>G
  • NG_007110.2:g.82630A>G
  • NM_000251.3:c.2516A>GMANE SELECT
  • NM_001258281.1:c.2318A>G
  • NP_000242.1:p.His839Arg
  • NP_000242.1:p.His839Arg
  • NP_001245210.1:p.His773Arg
  • LRG_218t1:c.2516A>G
  • LRG_218:g.82630A>G
  • LRG_218p1:p.His839Arg
  • NC_000002.11:g.47707892A>G
  • NM_000251.1:c.2516A>G
  • NM_000251.2:c.2516A>G
  • P43246:p.His839Arg
  • p.H839R
Protein change:
H773R
Links:
UniProtKB: P43246#VAR_043788; dbSNP: rs63750027
NCBI 1000 Genomes Browser:
rs63750027
Molecular consequence:
  • NM_000251.3:c.2516A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001258281.1:c.2318A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Malignant tumor of breast
Synonyms:
Malignant breast neoplasm; Cancer breast
Identifiers:
MONDO: MONDO:0007254; MedGen: C0006142

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001548627Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)

See additional submitters

no assertion criteria provided
Uncertain significanceunknownclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV001548627.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The MSH2 p.His839Arg variant was identified in 3 of 428 proband chromosomes (frequency: 0.007) from individuals or families with Lynch syndrome and was not identified in 400 control chromosomes from healthy individuals (Tang 2009, Wang 2006, Yuan 2004). The variant was also identified in dbSNP (ID: rs63750027) as "With Uncertain significance allele" and in ClinVar (classified as likely benign by Invitae; and as uncertain significance by InSiGHT, Ambry Genetics, GeneDx and one other submitter). The variant was not identified in UMD-LSDB. The variant was identified in 8 of 277214 chromosomes at a frequency of 0.00003 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Other in 1 of 6468 chromosomes (freq: 0.0002) and East Asian in 7 of 18866 chromosomes (freq: 0.0004), but was not observed in the African, Latino, European, Ashkenazi Jewish, Finnish, or South Asian populations. Functional and structural analysis of the variant showed reduced protein expression as well as altered RNA structure and MutSα dimerization (Arora 2017). The p.His839 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024